title: The pharmacology and subacute toxicology of dopamine.
abstract: Preclinical studies with dopamine showed a unique spectrum of biological activities which suggested that it might be of therapeutic use in the clinical syndromes of shock and low cardiac output. Most prominent among these were its effects on cardiac output, renal perfusion, and vital organ flow. The unique effect on renal function and the subsequent studies by Goldberg and his colleagues led to the recognition of a previously unknown catecholamine receptor site, the 'dopaminergic receptor'. Studies on the toxicology of dopamine in our laboratories suggested that dopamine could be safely used in the clinic.
mesh_terms: D000818:Animals; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology* / Q000633:toxicity; D007262:Infusions, Intravenous; D051379:Mice; D051381:Rats; D011919:Rats, Inbred Strains; D013045:Species Specificity
chemical_list: D004298:Dopamine
references.citation: Proc Soc Exp Biol Med. 1965 Jun;119:373-6
references.pmid: 14328894
references.citation: J Pharmacol Exp Ther. 1964 Jul;145:64-70
references.pmid: 14209513
references.citation: J Pharm Pharmacol. 1966 Apr;18(4):261-2
references.pmid: 4381257
references.citation: Br J Pharmacol. 1975 Dec;55(4):475-86
references.pmid: 1212559
references.citation: Proc Soc Exp Biol Med. 1971 Jan;136(1):268-70
references.pmid: 5540622
references.citation: Prog Cardiovasc Dis. 1969 Jul;12(1):40-51
references.pmid: 5807585
references.citation: J Pharmacol Exp Ther. 1967 May;156(2):310-24
references.pmid: 6026261
references.citation: N Engl J Med. 1966 Dec 22;275(25):1389-98
references.pmid: 5957632
references.citation: J Pharmacol Exp Ther. 1966 Jan;151(1):23-31
references.pmid: 5902175